ALTIMMUNE, INC. Other Non-Current Liabilities
ALTIMMUNE, INC. (ALT) had Other Non-Current Liabilities of $5.76 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-12
- 2026-06-30: Other Liabilities, Noncurrent $5.76M.
- 2026-03-31: Other Liabilities, Noncurrent $5.82M.
- 2025-12-31: Other Liabilities, Noncurrent $5.75M.
- 2025-09-30: Other Liabilities, Noncurrent $5.79M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $5.76M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $5.82M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $5.75M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $5.79M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $5.43M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $16.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $5.33M 10-K · filed 2026-03-06 | $22.00K 10-K · filed 2025-02-27 |
| 2024-09-30 | $26.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $31.00K 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $37.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $40.00K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $46.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $52.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $56.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $60.00K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $66.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $372.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $402.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $80.00K 10-K · filed 2023-02-28 | $80.54K 10-K · filed 2022-03-15 |
| 2021-09-30 | $85.49K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $90.44K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $95.38K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $110.32K 10-K · filed 2022-03-15 | |
| 2020-09-30 | $115.27K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $110.25K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $115.22K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $130.20K 10-K · filed 2021-02-25 | $120.20K 10-K · filed 2020-03-27 |
| 2019-09-30 | $225.17K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $230.15K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $235.12K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $140.09K 10-K · filed 2020-03-27 | $240.09K 10-K · filed 2019-04-01 |
| 2017-12-31 | $159.99K 10-K · filed 2019-04-01 | |
| 2017-03-31 | $442.59K 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $442.59K 10-Q · filed 2017-05-03 | |
| 2016-09-30 | $427.08K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $411.64K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $424.21K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $433.41K 10-K · filed 2017-03-14 | |
| 2015-09-30 | $431.01K 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $462.62K 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $485.37K 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $493.14K 10-K · filed 2016-03-11 | |
| 2014-09-30 | $507.07K 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $572.85K 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $602.40K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $588.75K 10-K · filed 2015-03-11 | |
| 2013-09-30 | $592.03K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $577.73K 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $580.24K 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $579.43K 10-K · filed 2014-03-11 | |
| 2012-09-30 | $579.71K 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $564.86K 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $555.98K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $449.71K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |